Renal Outcomes of Vasopressin and Its Analogs in Distributive Shock: A Systematic Review and Meta-Analysis of Randomized Trials

Critical Care Medicine

Volumn 47, Issue 1, 2019, Pages E44-E51

  Nedel, Wagner L ^a,b,c   Rech, Tatiana H ^a,b   Ribeiro, Rodrigo A ^b,d   Pellegrini, José Augusto S ^a   Moraes, Rafael B ^a,c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Graduate Program in Assessment Technology for the National Health System SUS   (Brazil)

^d FACULDADE MERIDIONAL IMED   (Brazil)

Author keywords

acute kidney injury; catecholamines; renal replacement therapy; shock; terlipressin; vasopressin

Indexed keywords

CATECHOLAMINE; TERLIPRESSIN; VASOPRESSIN; VASOPRESSIN DERIVATIVE; VASOCONSTRICTOR AGENT;

ACUTE KIDNEY FAILURE; ADULT; COCHRANE LIBRARY; DATA EXTRACTION; DISTRIBUTIVE SHOCK; EMBASE; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; MEDLINE; META ANALYSIS; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; SEPTIC SHOCK; SHOCK; SYSTEMATIC REVIEW; VASOPLEGIC SHOCK; COMPLICATION;

ACUTE KIDNEY INJURY; HUMANS; INCIDENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL REPLACEMENT THERAPY; SHOCK; TERLIPRESSIN; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 85058892992     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000003471     Document Type: Review

References (39)

1. Rhodes A, Evans LE, Alhazzani W, et al: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43:304-377
2. De Backer D, Biston P, Devriendt J, et al; SOAP II Investigators: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362:779-789
3. Dünser MW, Hasibeder WR: Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress. J Intensive Care Med 2009; 24:293-316
4. Avni T, Lador A, Lev S, et al: Vasopressors for the treatment of septic shock: Systematic review and meta-analysis. PLoS One 2015; 10:e0129305
5. Belletti A, Musu M, Silvetti S, et al: Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS One 2015; 10:e0142605
6. Bellomo R, Wan L, May C: Vasoactive drugs and acute kidney injury. Crit Care Med 2008; 36:S179-S186
7. Bellomo R, Kellum JA, Ronco C, et al: Acute kidney injury in sepsis. Intensive Care Med 2017; 43:816-828
8. O'Callaghan DJ, Gordon AC: What's new in vasopressin? Intensive Care Med 2015; 41:2177-2179
9. Bagshaw SM, Uchino S, Bellomo R, et al; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007; 2:431-439
10. Bouchard J, Acharya A, Cerda J, et al: A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol 2015; 10:1324-1331
11. Holmes CL, Walley KR, Chittock DR, et al: The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27:1416-1421
12. Gordon AC, Russell JA, Walley KR, et al: The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 2010; 36:83-91
13. Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
14. Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, et al: Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomized controlled trial. Anesthesiology 2017; 126:85-93
15. Higgins JP, Altman DG, Gøtzsche PC, et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group: The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343:d5928
16. Morelli A, Ertmer C, Rehberg S, et al: Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): A randomized, controlled pilot study. Crit Care 2009; 13:R130
17. Acevedo JG, Fernandez J, Escorsell A, et al: Clinical efficacy and safety of terlipressin administration in cirrhotic patients with septic shock. J Hepatol 2009; 50:S73
18. Albanèse J, Leone M, Delmas A, et al: Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study. Crit Care Med 2005; 33:1897-1902
19. Barzegar E, Ahmadi A, Mousavi S, et al: The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: Microcirculation, is it the black box? Acta Med Iran 2016; 54:15-23
20. Choudhury AK, Vashishtha C, Saini D, et al: A prospective open label randomized noninferiority trial to compare the efficacy and safety of monotherapy with noradrenaline and terlipressin in patients of cirrhosis with septic shock admitted to the intensive care unit (nct01836224). Hepatology 2014; 60:254A-255A
21. Dünser MW, Mayr AJ, Ulmer H, et al: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 2003; 107:2313-2319
22. Gordon AC, Mason AJ, Thirunavukkarasu N, et al; VANISH Investigators: Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA 2016; 316:509-518
23. Hajjar L, Roquim A, Kalil Filho R, et al: Vasopressin versus norepinephrine infusion in patients with vasoplegic shock after cardiac surgery. Crit Care 2009; 13:S75
24. Lauzier F, Lévy B, Lamarre P, et al: Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial. Intensive Care Med 2006; 32:1782-1789
25. Malay MB, Ashton RC Jr, Landry DW, et al: Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47:699-703; discussion 703-705
26. Morelli A, Ertmer C, Lange M, et al: Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: The DOBUPRESS study. Br J Anaesth 2008; 100:494-503
27. Okamoto Y, Nohmi T, Higa Y, et al: Vasopressin does not raise cardiac enzymes following cardiac surgery: A randomized double-blind clinical trial. J Cardiothorac Vasc Anesth 2015; 29:46-51
28. Patel BM, Chittock DR, Russell JA, et al: Beneficial effects of shortterm vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582
29. Xiao X, Zhang J, Wang Y, et al: Effects of terlipressin on patients with sepsis via improving tissue blood flow. J Surg Res 2016; 200:274-282
30. Gordon AC, Russell JA, Walley KR, et al: The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 2010; 36:83-91
31. Dünser MW, Mayr AJ, Ulmer H, et al: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 2003; 107:2313-2319
32. Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
33. Morelli A, Ertmer C, Lange M, et al: Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: The DOBUPRESS study. Br J Anaesth 2008; 100:494-503
34. Belletti A, Castro ML, Silvetti S, et al: The effect of inotropes and vasopressors on mortality: A meta-analysis of randomized clinical trials. Br J Anaesth 2015; 115:656-675
35. Pereira VGM, Serpa Neto A, Cardoso SO, et al: Vasopressin and terlipressin in adult vasodilatory shock: A systematic review and meta-analysis of nine randomized controlled trials. Crit Care 2013; 17:11
36. McIntyre WF, Um KJ, Alhazzani W, et al: Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: A systematic review and meta-analysis. JAMA 2018; 319:1889-1900
37. Bellomo R, Vaara ST, Kellum JA: How to improve the care of patients with acute kidney injury. Intensive Care Med 2017; 43:727-729
38. Barnett A, Graves N: Competing risks models and time-dependent covariates. Crit Care 2008; 12:134
39. Grunkemeier GL, Jin R, Eijkemans MJ, et al: Actual and actuarial probabilities of competing risks: Apples and lemons. Ann Thorac Surg 2007; 83:1586-1592